Evidence map›Paper›PMID 31242562›Full record

ReviewToxics2019

Biological Evaluation of DNA Biomarkers in a Chemically Defined and Site-Specific Manner.

Ke Bian, James C Delaney, Xianhao Zhou, Deyu Li

Open access · goldAbstract readReview
In one paragraph

Review in Toxics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ke BianDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA. kebian@uri.edu.ORCID 0000-0002-1268-2382
James C DelaneyVisterra, Inc., 275 Second Avenue, Waltham, MA 02451, USA. delaney@mit.edu.
Xianhao ZhouDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA. xianhao_zhou@my.uri.edu.
Deyu LiDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA. deyuli@uri.edu.
University of Rhode Island · USVisterra (United States) · US

Funding

Mutational spectra of bulky DNA lesionsR01ES028865 · NIEHS · UNIVERSITY OF RHODE ISLAND · PI LI, DEYU · 2018 to 2022
$2.1M
Inhibitory Effect of Nitric Oxide on DNA Repair EnzymesR15CA213042 · NCI · UNIVERSITY OF RHODE ISLAND · PI LI, DEYU · 2017 to 2017
$411k
National Institutes of Health R01 ES028865National Institutes of Health R15 CA213042NCI NIH HHS R15 CA213042NIEHS NIH HHS R01 ES028865
6 · The paper itself

Abstract

As described elsewhere in this Special Issue on biomarkers, much progress has been made in the detection of modified DNA within organisms at endogenous and exogenous levels of exposure to chemical species, including putative carcinogens and chemotherapeutic agents. Advances in the detection of damaged or unnatural bases have been able to provide correlations to support or refute hypotheses between the level of exposure to oxidative, alkylative, and other stresses, and the resulting DNA damage (lesion formation). However, such stresses can form a plethora of modified nucleobases, and it is therefore difficult to determine the individual contribution of a particular modification to alter a cell's genetic fate, as measured in the form of toxicity by stalled replication past the damage, by subsequent mutation, and by lesion repair. Chemical incorporation of a modification at a specific site within a vector (site-specific mutagenesis) has been a useful tool to deconvolute what types of damage quantified in biologically relevant systems may lead to toxicity and/or mutagenicity, thereby allowing researchers to focus on the most relevant biomarkers that may impact human health. Here, we will review a sampling of the DNA modifications that have been studied by shuttle vector techniques.

Indexed as

DNA adduct bypassDNA damageDNA lesionDNA repairmutagenicitymutational signaturemutational spectrumreplication blockshuttle vector techniquesite-specific mutagenesis

Identifiers

PMID31242562
PMCPMC6631660
OpenAlexW2951490533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.